Combination Therapy with an SGLT2 Inhibitor as Initial Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis

Background: Guidelines differ with regard to indications for initial combination pharmacotherapy for type 2 diabetes. Aims: To compare the efficacy and safety of (i) sodium-glucose cotransporter 2 (SGLT2) inhibitor combination therapy in treatment-naïve type 2 diabetes adults; (ii) initial high and...

Descripción completa

Detalles Bibliográficos
Autores principales: Milder, Tamara Y., Stocker, Sophie L., Abdel Shaheed, Christina, McGrath-Cadell, Lucy, Samocha-Bonet, Dorit, Greenfield, Jerry R., Day, Richard O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352265/
https://www.ncbi.nlm.nih.gov/pubmed/30621212
http://dx.doi.org/10.3390/jcm8010045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352265/
https://www.ncbi.nlm.nih.gov/pubmed/30621212
http://dx.doi.org/10.3390/jcm8010045

Ejemplares similares